![Keurig Dr Pepper Inc. Website](https://cdn.finchat.io/334622.png)
Keurig Dr Pepper Inc.
NasdaqGS-KDP
Company Overview
Keurig Dr Pepper Inc. operates as a beverage company in the United States and internationally. It operates through Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages segments. The Coffee Systems segment manufactures and distributes various finished goods related to its coffee systems, K-Cup pods, and brewers, as well as specialty coffee. This segment sells its brewers through third-party distributors and retail partners, as well as through its website at keurig.com. The Packaged Beverages segment engages in the manufacture and distribution of packaged beverages of its brands; contract manufacturing of various private label and emerging brand beverages; and distribution of packaged beverages for its partner brands. The Beverage Concentrates segment manufactures and sells beverage concentrates primarily under the Dr Pepper, Canada Dry, A&W, 7UP, Sunkist, Squirt, Big Red, RC Cola, Vernors, Snapple, Mott's, Bai, Hawaiian Punch, Clamato, Yoo-Hoo, Core, ReaLemon, evian, Vita Coco, and Mr and Mrs T mixers brands. This segment also manufactures beverage concentrates into syrup. The Latin America Beverages segment manufactures and distributes carbonated mineral water, flavored carbonated soft drinks, bottled water, and vegetable juice products under the Peñafiel, Clamato, Squirt, Dr Pepper, Crush, and Aguafiel brands. The company serves retailers, bottlers and distributors, restaurants, hotel chains, office coffee distributors, and end-use consumers. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Burlington, Massachusetts.
Name
Keurig Dr Pepper Inc.
CEO
Mr. Timothy P. Cofer
Website
www.keurigdrpepper.com
Sector
Beverages
Year Founded
1981
Profile
Market Cap
$49.99B
EV
$66.3B
Shares Out
1,356.09M
Revenue
$15.06B
Employees
28,100
Margins
Gross
55.82%
EBITDA
28.07%
Operating
23.2%
Pre-Tax
18.78%
Net
14.47%
FCF
7.1%
Returns (5Yr Avg)
ROA
3.32%
ROTA
-1,146.33%
ROE
6.91%
ROCE
6.77%
ROIC
4.57%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$36.86
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$438M
Net Debt
$16.31B
Debt/Equity
0.68
EBIT/Interest
5.12
Growth (CAGR)
Rev 3Yr
7.33%
Rev 5Yr
6.76%
Rev 10Yr
—
Dil EPS 3Yr
10.76%
Dil EPS 5Yr
18.28%
Dil EPS 10Yr
—
Rev Fwd 2Yr
3.94%
EBITDA Fwd 2Yr
5.62%
EPS Fwd 2Yr
7.53%
EPS LT Growth Est
7.3%
Dividends
Yield
—
Payout
54.51%
DPS
$0.86
DPS Growth 3Yr
10.49%
DPS Growth 5Yr
7.47%
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
5.17%